DOACs with Potent P2Y12 Inhibitors Raise Bleeding Risk in AF and ACS Patients
Published in Nature Medicine and presented at the 2026 European Society of Cardiology Congress, a study revealed that pairing direct oral anticoagulants with potent P2Y12 inhibitors in patients with atrial ... Read More